Stockreport

Wall Street Analysts Think ImmunityBio (IBRX) Could Surge 184.43%: Read This Before Placing a Bet [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF While analysts' price targets can be misleading, a strong agreement among them about the company's earnings prospects and a recent increase in EPS estimates suggest a po [Read more]